Min Chul Hee, Zhu Xuping, Grogg Kira, El Fakhri Georges, Winey Brian, Paganetti Harald
Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA Department of Radiological Science and Research Institute of Health Science, Yonsei University, Wonju, Kangwon, Republic of Korea.
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Technol Cancer Res Treat. 2015 Jun;14(3):320-5. doi: 10.1177/1533034614547457. Epub 2014 Sep 21.
We describe the rationale and implementation of a method for analyzing in-room positron emission tomography (PET) data to verify the proton beam range. The method is based on analyzing distal PET surfaces after passive scattering proton beam delivery. Typically in vivo range verification is done by comparing measured and predicted PET distribution for a single activity level at a selected activity line along the beam passage. In the method presented here, we suggest using a middle point method based on dual PET activity levels to minimize the uncertainty due to local variations in the PET activity. Furthermore, we introduce 2-dimensional (2D) PET activity level surfaces based on 3-dimensional maps of the PET activities along the beam passage. This allows determining not only average range differences but also range difference distributions as well as root mean square deviations (RMSDs) for a more comprehensive range analysis. The method is demonstrated using data from 8 patients who were scanned with an in-room PET scanner. For each of the 8 patients, the average range difference was less than 5 mm and the RMSD was 4 to 11 mm between the measured and simulated PET activity level surfaces for single-field treatments. An ongoing protocol at our institution allows the use of a single field for patients being imaged for the PET range verification study at 1 fraction during their treatment course. Visualizing the range difference distributions using the PET surfaces offers a convenient visual verification of range uncertainties in 2D. Using the distal activity level surfaces of simulated and measured PET distributions at the middle of 25% and 50% activity level is a robust method for in vivo range verification.
我们描述了一种用于分析室内正电子发射断层扫描(PET)数据以验证质子束射程的方法的基本原理和实施过程。该方法基于在被动散射质子束传输后分析PET远端表面。通常,体内射程验证是通过比较沿束流通道在选定活性线上单一活性水平下测量的和预测的PET分布来完成的。在此提出的方法中,我们建议使用基于双PET活性水平的中点法,以尽量减少由于PET活性局部变化导致的不确定性。此外,我们基于沿束流通道的PET活性三维图引入二维(2D)PET活性水平表面。这不仅允许确定平均射程差异,还能确定射程差异分布以及均方根偏差(RMSD),以便进行更全面的射程分析。使用来自室内PET扫描仪扫描的8名患者的数据对该方法进行了验证。对于这8名患者中的每一位,在单野治疗中,测量的和模拟的PET活性水平表面之间的平均射程差异小于5毫米,RMSD为4至11毫米。我们机构正在进行的一项方案允许在患者治疗过程中的1次分割时,对进行PET射程验证研究成像的患者使用单野。使用PET表面可视化射程差异分布为二维射程不确定性提供了方便的视觉验证。在25%和50%活性水平的中点使用模拟和测量的PET分布的远端活性水平表面是一种用于体内射程验证的可靠方法。